Radiopharmaceuticals Global Market Report 2021: COVID 19 Growth And Change To 2030

The Business Research Company’s Radiopharmaceuticals Global Market Report 2021: COVID 19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, August 10, 2021 /EINPresswire.com/ -- According to the new market research report ‘Radiopharmaceuticals Global Market Report 2021: COVID-19 Growth and Change To 2030’ published by The Business Research Company, the radiopharmaceuticals market is expected to grow from $4.78 billion in 2020 to $5.12 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.75 billion in 2025 at a CAGR of 7%. The increasing prevalence of cancer and cardiovascular diseases is projected to drive the demand for the radiopharmaceuticals market.

Request For a Sample for The Global Radiopharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in treating cancer, cardiovascular, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.

Trends In the Global Radiopharmaceuticals Market
Research collaborations and partnerships are gaining significant popularity in the radiopharmaceuticals market over recent years. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business. For instance, in March 2020, Debi pharms, a Switzerland-based biopharmaceutical company, signed a research agreement with 3B Pharmaceuticals (3BP), a Germany-based biotechnology firm, to develop the Debi 0228 radioligand program, targeting CAIX (Carbonic Anhydrase 9) enzyme to fight the progression of cancer.

Global Radiopharmaceuticals Market Segments:
The global radiopharmaceuticals market is further segmented based on type, application, end user and geography.
By Type: Diagnostic, Therapeutic, Others
By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others
By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
By Geography: The global radiopharmaceuticals market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More on The Report for The Global Radiopharmaceuticals Market At:
https://www.thebusinessresearchcompany.com/report/radiopharmaceuticals-global-market-report-2020-30-covid-19-growth-and-change

Radiopharmaceuticals Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals global market overviews, analyzes and forecasts market size and growth for the global radiopharmaceuticals market, radiopharmaceuticals market share, radiopharmaceuticals global market players, radiopharmaceuticals global market segments and geographies, radiopharmaceuticals market’s leading competitors’ revenues, profiles and market shares. The radiopharmaceuticals global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Radiopharmaceuticals Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region and By Country; Historic and Forecast Size, And Growth Rates for The World, 7 Regions And 12 Countries

Radiopharmaceuticals Market Organizations Covered: Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Nordion Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc, Curium, Eckert & Ziegler, Eli Lilly, Eckert & Ziegler, IBA Group, Merck & Co. Inc., Philips Healthcare, Fujifilm Holding Corporation, Areva Pharma, Navidea Biopharmaceuticals Inc., Actinium Pharmaceuticals Inc., Global Medical Solutions LTD., Shine Medical Technologies.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Radiopharmaceuticals Global Market Report 2021:

Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And by Region, Opportunities and Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-market

Cardiovascular Drugs Global Market Report 2021 - By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2020-30-covid-19-impact-and-recovery

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.